providers are adequately trained on anticoagulant options to provide informed recommendations when engaging in shared decision-making. Warfarin adherence can be assessed through INR monitoring. There have been concerns about adherence with LMWH given that
Search Results
Jordan K. Schaefer, Amro Elshoury, Victoria R. Nachar, Michael B. Streiff, and Ming Y. Lim
Julie Hallet, Calvin Law, Simron Singh, Alyson Mahar, Sten Myrehaug, Victoria Zuk, Haoyu Zhao, Wing Chan, Angela Assal, and Natalie Coburn
critical in guiding decisions regarding care, monitoring strategies, aggressiveness of therapy, and patient counseling to enable shared decision-making. 10 Yet, although overall survival, recurrence-free survival, and associated prognostic factors have
Therese B. Bevers, John H. Ward, Banu K. Arun, Graham A. Colditz, Kenneth H. Cowan, Mary B. Daly, Judy E. Garber, Mary L. Gemignani, William J. Gradishar, Judith A. Jordan, Larissa A. Korde, Nicole Kounalakis, Helen Krontiras, Shicha Kumar, Allison Kurian, Christine Laronga, Rachel M. Layman, Loretta S. Loftus, Martin C. Mahoney, Sofia D. Merajver, Ingrid M. Meszoely, Joanne Mortimer, Lisa Newman, Elizabeth Pritchard, Sandhya Pruthi, Victoria Seewaldt, Michelle C. Specht, Kala Visvanathan, Anne Wallace, Mary Ann Bergman, and Rashmi Kumar
Survival estimates generated from this model can facilitate shared decision-making regarding choice of a risk reduction approach (see Table 2; available online, in these guidelines, at NCCN.org ). A prospective multicenter study reported the benefit of
Elizabeth A. Nardi, Lisa Korin Lentz, Katherine Winckworth-Prejsnar, Amy P. Abernethy, and Robert W. Carlson
not acting in isolation. 22 In turn, this can help with shared decision-making, leading to patients making informed choices. Technology, it seems, should be a trust broker and accelerator. 23 Disparate data sources, such as EHRs, administrative and
Timothy J. Wilt and Philipp Dahm
decision making on cancer screening—a systematic review . Washington, DC : Department of Veterans Affairs (US) ; 2014 . 34. Carlsson S Assel M Sjoberg D . Influence of blood prostate specific antigen levels at age 60 on benefits and harms of
Emma Gargus, Rebecca Deans, Antoinette Anazodo, and Teresa K. Woodruff
lower breast cancer risk than premenopausal survivors (HR, 0.47; 95% CI, 0.23–0.94), indicating that exogenous hormones do not fully mirror the role of endogenous hormones in the development of breast cancer. 83 Using shared decision-making, providers
Matthew E. Nielsen, Bruce J. Trock, and Patrick C. Walsh
pathological features alone or initial observation with salvage RT in the event of biochemical recurrence remains a complex and controversial question that should be addressed with shared decision-making. The authors have disclosed that they have no
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 2.2019
Featured Updates to the NCCN Guidelines
Samir Gupta, Dawn Provenzale, Xavier Llor, Amy L. Halverson, William Grady, Daniel C. Chung, Sigurdis Haraldsdottir, Arnold J. Markowitz, Thomas P. Slavin Jr, Heather Hampel, CGC, Reid M. Ness, Jennifer M. Weiss, Dennis J. Ahnen, Lee-may Chen, Gregory Cooper, Dayna S. Early, Francis M. Giardiello, Michael J. Hall, Stanley R. Hamilton, Priyanka Kanth, Jason B. Klapman, Audrey J. Lazenby, Patrick M. Lynch, Robert J. Mayer, June Mikkelson, CGC, Shajan Peter, Scott E. Regenbogen, Mary A. Dwyer, CGC, and Ndiya Ogba
assessment identifies factors associated with increased risk. The 2019 update included a section on principles of cancer risk assessment and counseling for individuals with potentially increased risk, which can guide shared decision-making regarding the need
NCCN Guidelines® Insights: Older Adult Oncology, Version 1.2021
Featured Updates to the NCCN Guidelines
Efrat Dotan, Louise C. Walter, Ilene S. Browner, Katherine Clifton, Harvey Jay Cohen, Martine Extermann, Cary Gross, Sumati Gupta, Genevieve Hollis, Joleen Hubbard, Reshma Jagsi, Nancy L. Keating, Elizabeth Kessler, Thuy Koll, Beatriz Korc-Grodzicki, June M. McKoy, Sumi Misra, Dominic Moon, Tracey O’Connor, Cynthia Owusu, Ashley Rosko, Marcia Russell, Mina Sedrak, Fareeha Siddiqui, Amy Stella, Derek L. Stirewalt, Ishwaria M. Subbiah, William P. Tew, Grant R. Williams, Liz Hollinger, Giby V. George, and Hema Sundar
, and allowing for a shared decision-making with the patient and/or caregiver. Although typically a thorough CGA is performed by a geriatric trained clinician, many of the tools can be applied to routine practice and conducted by providers without any
William J. Gradishar, Benjamin O. Anderson, Jame Abraham, Rebecca Aft, Doreen Agnese, Kimberly H. Allison, Sarah L. Blair, Harold J. Burstein, Chau Dang, Anthony D. Elias, Sharon H. Giordano, Matthew P. Goetz, Lori J. Goldstein, Steven J. Isakoff, Jairam Krishnamurthy, Janice Lyons, P. Kelly Marcom, Jennifer Matro, Ingrid A. Mayer, Meena S. Moran, Joanne Mortimer, Ruth M. O'Regan, Sameer A. Patel, Lori J. Pierce, Hope S. Rugo, Amy Sitapati, Karen Lisa Smith, Mary Lou Smith, Hatem Soliman, Erica M. Stringer-Reasor, Melinda L. Telli, John H. Ward, Jessica S. Young, Jennifer L. Burns, and Rashmi Kumar
chemotherapy in an individual patient typically depends on the efficacy and tolerability and shared decision-making between the treating physician and patient. Most patients will be candidates for multiple lines of systemic therapies for palliation. At each
